Content area
DNA Script SAS - Medical Equipment - Deals and Alliances Profile
DNA Script SAS (DNA Script) is a biotechnology company that develops and distributes DNA synthesis technology using enzymatic methods. The company utilizes the SYNTAX Platform for molecular biologics and genomics applications. It offers SYNTAX system, SYNTAX kits, SYNTAX system software and console software. Its enzymatic DNA synthesis (EDS) products include the SYNTAX STX-200 system and SYNTAX STX-100 system. DNA Script’s SYNTAX kits include SYNTAX 96 hi-fidelity kit, SYNTAX 96 standard kit and SYNTAX 192 label kit. It operates in the US and France. DNA Script is headquartered in Paris, Ile-de-France, France
DNA Script SAS - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.